Valproate vs Lithium

How they're similar

Both drugs are classified as mood stabilizers, which is a functional label rather than a mechanistic one. Both treat acute mania and both are used to prevent future mood episodes in bipolar disorder. Both have been around long enough that clinicians have a lot of practical experience with how they behave, what their side effects look like, and how to monitor them.

Both require blood level monitoring because their therapeutic index is narrow. The gap between a level that works and a level that causes toxicity is small, so periodic labs are part of the deal with either drug. Both can cause tremor as a side effect at therapeutic levels, and both cause worse tremor as levels rise. Both can cause GI upset, especially early on, and both can cause weight gain over time.

Both need dose adjustments when other things in the medical picture change. Kidney function affects lithium, liver function affects valproate. New medications, changes in sodium intake, dehydration, and hormonal shifts can all move levels. Both drugs benefit from a stable routine and a person who can reliably show up for blood draws every few months at minimum.

Both are available as inexpensive generics. Neither is a controlled substance. Both are used off-label for a range of conditions beyond their approved uses, including migraine prevention (both), impulsivity or aggression (both), and certain personality disorder features (both, though evidence is thin).

How they differ

The mechanisms are different in a way that probably matters clinically, even though we don't fully understand the details. Lithium is a monovalent cation, an actual element, and it works through effects on second-messenger systems inside cells, particularly on inositol signaling and on GSK-3. Valproate is a fatty acid that inhibits GABA breakdown, blocks voltage-gated sodium channels, and has effects on histone deacetylases and gene expression. These are very different mechanisms, and it's not just theoretical. The two drugs have measurably different effects on different aspects of bipolar disorder.

The strongest evidence for lithium is in classic euphoric mania and in long-term relapse prevention, and it's the only psychiatric medication with clear evidence for reducing suicide risk. That last point is worth its own weight. In a disorder where suicide is a leading cause of death, having a medication that lowers that risk in a measurable way is a serious consideration. Valproate hasn't shown that same signal. It works well for acute mania, often faster than lithium (5 to 7 days versus 1 to 2 weeks), and it tends to be more effective in mixed episodes and in rapid cycling.

Pregnancy is one of the biggest split points. Valproate is contraindicated during pregnancy in most cases. It has a 2 to 5 percent risk of neural tube defects like spina bifida, and there's also evidence that in-utero exposure lowers IQ and increases developmental problems in exposed children. It's also linked to polycystic ovary syndrome in women of reproductive age. For any woman of childbearing potential, this needs to be part of the conversation before starting the drug, and reliable contraception is often part of the plan. Lithium has some pregnancy risk too, most notably a small increased risk of Ebstein's anomaly (a heart defect), but the risk is much smaller than with valproate, and lithium is often continued during pregnancy with careful monitoring when the alternative is destabilization.

The monitoring picture is different too. Lithium requires periodic checks of the drug level, TSH (because lithium can cause hypothyroidism), and creatinine or eGFR (because long-term use can affect kidney function). Calcium may be added because lithium can raise it modestly. Valproate requires periodic checks of the level, liver enzymes (LFTs), and a CBC because it can lower platelets. Ammonia is only checked when someone gets confused or sedated in a way that suggests hyperammonemia, which is rare.

Side effect tendencies

Both drugs cause tremor. Lithium tremor is usually a fine hand tremor that gets worse as the level rises or with caffeine, stress, or fatigue. Valproate tremor is similar. Both can be managed with dose reduction, propranolol, or timing changes.

Weight gain is common with both, and often more pronounced with valproate. People sometimes gain 10 to 20 pounds over months on valproate, and once it's on, it can be hard to lose without either a switch or serious lifestyle intervention. Lithium also causes weight gain, though usually less. Both are worth naming up front so the plan includes some form of monitoring.

Lithium has a distinct set of long-term concerns. It can cause nephrogenic diabetes insipidus, which shows up as excessive thirst and urination because the kidneys stop responding well to antidiuretic hormone. Over years, lithium can also affect kidney function itself, sometimes progressing to chronic kidney disease. That's why creatinine and eGFR are checked regularly. Lithium can cause hypothyroidism, sometimes needing thyroid hormone replacement. It can also cause acne and hair changes. Toxicity signs include coarse tremor, GI upset, ataxia, slurred speech, and confusion. Levels above 1.5 mEq/L are usually the toxicity zone, and levels above 2.0 are dangerous.

Valproate has its own long-term concerns. Hepatotoxicity is rare but can be serious, most often in the first six months and more common in children under 2 or in people with underlying liver disease. Pancreatitis is rare but possible. Thrombocytopenia (low platelets) is common at higher levels and usually mild. Hair thinning and alopecia are common and often reversible, sometimes with zinc or selenium supplementation. In women, PCOS-like features (irregular periods, weight gain, insulin resistance, hyperandrogenism) are a real concern with long-term use during reproductive years.

Interactions are a bigger issue with valproate. It's a substrate for CYP2C9 and CYP2C19, and it inhibits several enzymes, most notably the ones that clear lamotrigine. When valproate and lamotrigine are combined, lamotrigine levels roughly double, and the lamotrigine dose has to be cut in half with a slower titration. Lithium's interactions are different in flavor. NSAIDs, ACE inhibitors, and thiazide diuretics can all raise lithium levels significantly by reducing kidney clearance, sometimes into the toxic range. A patient on lithium who starts ibuprofen for a knee injury and drinks less water in the summer heat can end up in the emergency room with lithium toxicity, and that story isn't rare.

What tips the choice

Diagnosis and episode type point strongly in some cases. Classic euphoric mania in someone with a family history that also responded to lithium is a straightforward lithium case. Mixed episodes, rapid cycling, or a person who needs mania control in days rather than weeks may tip toward valproate. Bipolar with a strong suicidality history is a lithium case unless there's a specific reason not to, given the suicide-reduction evidence.

Pregnancy planning changes everything. For a woman who might become pregnant, valproate is usually avoided unless there's no reasonable alternative, and if it's used, reliable contraception is part of the plan. Lithium is often the safer mood stabilizer in that scenario, with careful monitoring during pregnancy and around delivery.

Kidney function tips against lithium if it's already impaired, and long-term lithium requires a person willing to show up for regular monitoring and to stay hydrated. Liver disease or a history of pancreatitis tips against valproate. In older adults, both need care, and both cause more toxicity at lower levels because clearance slows.

Prior response counts a lot in bipolar. If a first-degree relative responded well to lithium, the person in front of you often does too. If lithium failed in the past despite a good trial at good levels, valproate may be the next reasonable step. Combination therapy is common when neither drug alone does enough, and lithium plus valproate is a widely used pairing when the picture is complex.

Practical fit matters too. Lithium needs a person who can drink water reliably, avoid regular NSAID use, come in for labs, and notice early signs of toxicity like coarse tremor or confusion. Valproate needs a person who can accept the weight gain risk, avoid alcohol in excess, and understand the pregnancy considerations.

Common questions

Which one reduces suicide risk? Lithium. It's the only psychiatric medication with clear evidence for reducing suicide risk in bipolar disorder, and the effect is meaningful in trials and in real-world data. Valproate hasn't shown that same signal. In someone with a serious suicidality history, this piece often carries a lot of weight in the decision.

Can I take either during pregnancy? Valproate is generally contraindicated in pregnancy because of neural tube defects and cognitive effects on the exposed child. It's usually only continued when there's no reasonable alternative. Lithium has some pregnancy risk, mainly a small increase in a specific heart defect (Ebstein's anomaly), but it's often continued during pregnancy with careful monitoring when the alternative is a serious bipolar relapse. Any decision about mood stabilizers in pregnancy is a conversation with both psychiatry and OB.

How often do I need blood work? For lithium, levels are usually checked every 3 to 6 months once stable, with TSH and creatinine every 6 to 12 months. For valproate, levels are checked similarly, with LFTs and CBC every 6 to 12 months. After any dose change, levels are usually rechecked in about 5 days. Both drugs need more frequent monitoring at the start of treatment and after any change.

Which causes more weight gain? Both can cause weight gain, and it's often more pronounced with valproate. It's not universal, but people on valproate often report meaningful weight gain over months, sometimes 10 to 20 pounds. Lithium also causes weight gain but usually less. Weight is worth tracking on either drug, and worth naming up front so the plan can include something proactive rather than reactive.

Can I combine them? Yes. Combination therapy with lithium and valproate is common in bipolar disorder when neither drug alone is enough. The combination isn't more toxic than either alone at appropriate levels, but it does mean more labs, more attention to interactions, and more medications to manage. It's often the right move for complex or hard-to-treat bipolar disorder.

Sources

This guide draws on current prescribing information and public health references. It is reviewed for clinical accuracy and updated as guidance changes.

1. U.S. Food and Drug Administration. Lithium prescribing information.
2. U.S. Food and Drug Administration. Valproate/divalproex sodium prescribing information.
3. MedlinePlus, U.S. National Library of Medicine.
4. National Institute of Mental Health. Bipolar disorder.